Cargando…

Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study

BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 po...

Descripción completa

Detalles Bibliográficos
Autores principales: Arguni, Eggi, Supriyati, Endah, Hakim, Mohamad Saifudin, Daniwijaya, Edwin Widyanto, Makrufardi, Firdian, Rahayu, Ayu, Rovik, Anwar, Saraswati, Utari, Oktoviani, Farida Nur, Prastiwi, Nenes, Nuryastuti, Titik, Wibawa, Tri, Haryana, Sofia Mubarika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055379/
https://www.ncbi.nlm.nih.gov/pubmed/35531428
http://dx.doi.org/10.1016/j.amsu.2022.103676
_version_ 1784697397093335040
author Arguni, Eggi
Supriyati, Endah
Hakim, Mohamad Saifudin
Daniwijaya, Edwin Widyanto
Makrufardi, Firdian
Rahayu, Ayu
Rovik, Anwar
Saraswati, Utari
Oktoviani, Farida Nur
Prastiwi, Nenes
Nuryastuti, Titik
Wibawa, Tri
Haryana, Sofia Mubarika
author_facet Arguni, Eggi
Supriyati, Endah
Hakim, Mohamad Saifudin
Daniwijaya, Edwin Widyanto
Makrufardi, Firdian
Rahayu, Ayu
Rovik, Anwar
Saraswati, Utari
Oktoviani, Farida Nur
Prastiwi, Nenes
Nuryastuti, Titik
Wibawa, Tri
Haryana, Sofia Mubarika
author_sort Arguni, Eggi
collection PubMed
description BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. RESULTS: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses. CONCLUSION: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19.
format Online
Article
Text
id pubmed-9055379
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90553792022-05-02 Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study Arguni, Eggi Supriyati, Endah Hakim, Mohamad Saifudin Daniwijaya, Edwin Widyanto Makrufardi, Firdian Rahayu, Ayu Rovik, Anwar Saraswati, Utari Oktoviani, Farida Nur Prastiwi, Nenes Nuryastuti, Titik Wibawa, Tri Haryana, Sofia Mubarika Ann Med Surg (Lond) Cross-sectional Study BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. RESULTS: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses. CONCLUSION: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19. Elsevier 2022-04-30 /pmc/articles/PMC9055379/ /pubmed/35531428 http://dx.doi.org/10.1016/j.amsu.2022.103676 Text en © 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Cross-sectional Study
Arguni, Eggi
Supriyati, Endah
Hakim, Mohamad Saifudin
Daniwijaya, Edwin Widyanto
Makrufardi, Firdian
Rahayu, Ayu
Rovik, Anwar
Saraswati, Utari
Oktoviani, Farida Nur
Prastiwi, Nenes
Nuryastuti, Titik
Wibawa, Tri
Haryana, Sofia Mubarika
Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title_full Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title_fullStr Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title_full_unstemmed Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title_short Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
title_sort co-infection of sars-cov-2 with other viral respiratory pathogens in yogyakarta, indonesia: a cross-sectional study
topic Cross-sectional Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055379/
https://www.ncbi.nlm.nih.gov/pubmed/35531428
http://dx.doi.org/10.1016/j.amsu.2022.103676
work_keys_str_mv AT argunieggi coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT supriyatiendah coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT hakimmohamadsaifudin coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT daniwijayaedwinwidyanto coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT makrufardifirdian coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT rahayuayu coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT rovikanwar coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT saraswatiutari coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT oktovianifaridanur coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT prastiwinenes coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT nuryastutititik coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT wibawatri coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy
AT haryanasofiamubarika coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy